Ethylhydrocupreine HCl

CAS : 3413-58-9

Ref. 3D-FE30579

Informations sur le produit

• Nom: Ethylhydrocupreine HCl
• Synonymes: Optochin, (3alpha,9R)-6'-ethoxy-10,11-dihydrocinchonan-1-ium-9-ol, (9R)-6'-ethoxy-10,11-dihydrocinchonan-1-ium-9-ol, 6'-Ethoxy-10,11-Dihydrocinchonan-9-Ol, Cinchonan-9-ol, 6'-ethoxy-10,11-dihydro-, monohydrochloride, (8alpha,9R)- (9CI), Cinchonan-9-ol, 6′-ethoxy-10,11-dihydro-, hydrochloride (1:1), (8α,9R)-, Cinchonan-9-ol, 6′-ethoxy-10,11-dihydro-, monohydrochloride, (8α,9R)-, Hydrocupreine, O-6'-ethyl-, monohydrochloride (VAN), Hydrocupreine, O-ethyl-, hydrochloride, Hydrocupreine, O^6′-ethyl-, monohydrochloride, Hydrocupreine, ethyl ester, hydrochloride, Neumolisina, Nsc 5361, Numoquin hydrochloride, O-Ethylhydrocupreine hydrochloride, Optochin hydrochloride, Optoquin hydrochloride, Optoquinhydrochloride, Rhombic, Hydrocupreine, O6′-ethyl-, monohydrochloride

Description

Ethylhydrocupreine HCl is a cavity treatment that is used to treat cancer. It is a laboratory diagnosis, which means it can be used to diagnose and monitor the progression of cancer. Ethylhydrocupreine HCI has been shown to have hemolytic activity against erythrocytes and has been shown in laboratory experiments to inhibit the growth of pneumococcus and other bacteria by interfering with DNA synthesis. Ethylhydrocupreine HCI is being studied as an anticancer agent that may prevent the spread of cancer cells. The drug binds to dsDNA, inhibiting replication and transcription, leading to cell death. Ethylhydrocupreine HCI also inhibits protein synthesis by binding to RNA polymerase and preventing elongation of RNA chains.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 376.92 g/mol
• Formule: C₂₁H₂₈N₂O₂·HCl
• Degré de pureté: Min. 95%
• Couleur/Forme: White Yellow Powder